More Articles
Withings, a French medtech company, has received U.S. Food and Drug Administration (FDA) clearance for…
Heart Rhythm Advocates, the advocacy arm of the Heart Rhythm Society (HRS), will host a virtual town hall meeting Tuesday, Nov. 18, at 7 p.m. ET to…
Black patients have a lower prevalence of atrial fibrillation (AFib) than white adults, but their outcomes and mortality are worse, so earlier identification of those who may be at higher risk for Afib is seen as a key to improve outcomes. New…
New-onset atrial fibrillation (AFib) after coronary artery bypass grafting (CABG) is relatively common, according to new data published in JAMA.[1] However, the AFib burden for these patients is low, especially after 30 days.
The…
Field Medical’s pulsed field ablation (PFA) technology may represent a significant step forward in the treatment of scar-related ventricular tachycardia (VT), according to a new first-in-human clinical trial published in Circulation.[1]…
Stereotaxis and CardioFocus, two U.S. medtech companies, are working together to push a robotic pulsed field ablation (PFA) system toward commercialization.
St. Louis-based Stereotaxis is already a known leader in the…
Cardiac ablation is one of the most important procedures in modern healthcare, allowing electrophysiologists to target irregular heart rhythms with precision and accuracy.
Ablation technology has experienced a breakthrough in recent…
The U.S. Food and Drug Administration (FDA) has finalized new recalls related to ongoing safety concerns with Boston Scientific’s Accolade family of pacemakers. The recalls cover more than 1 million devices.…
Massachusetts-based Zoll has received U.S. Food and Drug Administration (FDA) approval for its Zenix defibrillator-monitor for EMS and hospital use. The device includes new…
San Diego-based Vektor Medical has gained CE mark approval for the vMap System, which uses artificial intelligence (AI) to turn 12-lead electrocardiograms (ECGs) into…
Boston Scientific announced at its Investor Day event Sept. 30 it plans to launch its fourth-generation Watchman left atrial appendage closure (LAAC) device, which will…
The use of augmented reality (AR) during cardiac ablation procedures may be improved by adding “virtual screens” that clinicians can customize as they see fit. That was the primary takeaway of a new analysis published in the Journal of…
Abbott has issued a warning on the proper handling of its TactiFlex Ablation Catheter, Sensor Enabled,…
A safety issue with certain Boston Scientific defibrillation leads has resulted in a series of new Class I recalls, according to the U.S. Food and Drug Administration (FDA). Unlike some recalls, these do not…
Boston Scientific has agreed to acquire Elutia’s drug-eluting envelope business for $88 million. The cash transaction is expected to close in late 2025.
Elutia is the Maryland-based medtech company behind…
Evaluating left ventricular diastolic function (LVDF) with echocardiography can help identify individuals at an increased risk of developing atrial fibrillation (AFib), according to new findings presented at the American…
In July, the Centers for Medicare and Medicaid Services (CMS) proposed adding procedure codes for cardiac ablations to the Ambulatory Surgical Center (ASC) Covered Procedures List as part of the…
The U.S. Food and Drug Administration (FDA) has granted pre-market approval (PMA) for the Globe Pulsed Field Ablation (PFA) System, along with 510(k) clearance for both the Globe introducer sheath and the Globe Pulsed Field System mapping…
Philips introduced a new cardiac monitoring telemetry platform designed to address critical challenges in healthcare, including staff shortages and alarm management. A key component of the solution is the next-generation…
There has been a movement in electrophysiology (EP) labs to adopt high-density mapping catheters that allow more detailed information on the electrical activity in…
Pulsed field ablation (PFA) with Johnson & Johnson MedTech’s Varipulse platform is safe and effective, according to new real-world data presented at ESC Congress 2025…